NERV (Minerva Neurosciences, Inc.) Stock Market Reviews

crown

search

Read and share opinions on NERV (Minerva Neurosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

NERV

Minerva Neurosciences, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Minerva Neurosciences: Q3 Earnings Snapshot
Nov 5, 2025
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
Nov 5, 2025
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
Oct 21, 2025
Minerva Neurosciences: Q2 Earnings Snapshot
Aug 14, 2025
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
Aug 14, 2025
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
May 13, 2025
Minerva Neurosciences: Q1 Earnings Snapshot
May 13, 2025
Minerva Neurosciences: Q4 Earnings Snapshot
Feb 25, 2025
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
Feb 25, 2025

Reviews